Nitrosylcobalamin Potentiates the Anti-Neoplastic Effects of Chemotherapeutic Agents via Suppression of Survival Signaling

• Joseph A. Bauer ,

  Contributed equally to this work with: Joseph A. Bauer, Joseph A. Lupica

  *To whom correspondence should be addressed. E-mail: bauerj@ccf.org (JAB); lindned@ccf.org (DJL)

  Affiliation Taussig Cancer Center, Center for Hematology and Oncology Molecular Therapeutics, The Cleveland Clinic Foundation, Cleveland, Ohio, United States of America

  ⨯
• Joseph A. Lupica ,

  Contributed equally to this work with: Joseph A. Bauer, Joseph A. Lupica

  Affiliations Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio, United States of America, Department of Chemistry, Cleveland State University, Cleveland, Ohio, United States of America

  ⨯
• Heidi Szugye,

  Affiliation Taussig Cancer Center, Center for Hematology and Oncology Molecular Therapeutics, The Cleveland Clinic Foundation, Cleveland, Ohio, United States of America

  ⨯
• Bei H. Morrison,

  Affiliation Taussig Cancer Center, Center for Hematology and Oncology Molecular Therapeutics, The Cleveland Clinic Foundation, Cleveland, Ohio, United States of America

  ⨯
• Rebecca M. Haney,

  Affiliation Taussig Cancer Center, Center for Hematology and Oncology Molecular Therapeutics, The Cleveland Clinic Foundation, Cleveland, Ohio, United States of America

  ⨯
• Rhonda K. Masci,

  Affiliation Taussig Cancer Center, Center for Hematology and Oncology Molecular Therapeutics, The Cleveland Clinic Foundation, Cleveland, Ohio, United States of America

  ⨯
• Rebecca M. Lee,

  Affiliation Taussig Cancer Center, Center for Hematology and Oncology Molecular Therapeutics, The Cleveland Clinic Foundation, Cleveland, Ohio, United States of America

  ⨯
• Joseph A. DiDonato,

  Affiliation Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio, United States of America

  ⨯
• Daniel J. Lindner

  *To whom correspondence should be addressed. E-mail: bauerj@ccf.org (JAB); lindned@ccf.org (DJL)

  Affiliations Taussig Cancer Center, Center for Hematology and Oncology Molecular Therapeutics, The Cleveland Clinic Foundation, Cleveland, Ohio, United States of America, Department of Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio, United States of America

  ⨯